Leveljump Healthcare Corp. Provides Updates on Telehospital Purchase; $2.5 Million Private Placement
Toronto, Ontario--(Newsfile Corp. - March 2, 2022) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("LevelJump" or the...
Day: March 2, 2022
C3 AI Announces Fiscal Third Quarter 2022 Financial Results
Revenue Growth of 42% year over year to $69.8 million Raises Guidance to Reflect FY 2022 Revenue Growth of 38%...
Digital Health Companies Orbita and OnCall Health Choose Lyniate for Reliable Interoperability
Increased Customer Demand Fueled by Pandemic and Market Forces BOSTON--(BUSINESS WIRE)--Lyniate, a global leader in healthcare data interoperability, continued to...
Hemostemix Announces $2,750,000 Convertible Debenture
Calgary, Alberta--(Newsfile Corp. - March 2, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is...
MediFind Establishes Medical Advisory Board Led by Dr. Kyle Hogarth of University of Chicago Medicine to Further Advance Development of Consumer-Centric Health Platform
PHILADELPHIA--(BUSINESS WIRE)--MediFind, a consumer-centric health technology company that uses advanced analytics to connect patients with leading health experts, today announced...
Scientific Industries Secures New Funding to Accelerate Growth of Its Bioprocessing Business
BOHEMIA, NY / ACCESSWIRE / March 2, 2022 / Scientific Industries, Inc. (OTCQB:SCND), a life sciences tool provider, and a...
Emergent Health Subsidiary PharmaZu Executes Agreement with DynaCord to Develop Various Injectable and Topical Biologic Exosomes for the Treatment of Arthritis, Joint Care, Wound Care, and Inflammation for Pets
KING OF PRUSSIA, PA / ACCESSWIRE / March 2, 2022 / Emergent Health Corp., (OTC PINK:EMGE) announces subsidiary PharmaZu executes...
Aytu BioPharma Announces AR101 Granted Orphan Designation in Europe for the Treatment of Ehlers-Danlos Syndrome
ENGLEWOOD, CO / ACCESSWIRE / March 2, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and...
9 Meters Biopharma Announces a Collaboration with NYU Langone Health Investigating NM-102 as a Potential Treatment for an Autoimmune Disorder
RALEIGH, NC / ACCESSWIRE / March 2, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments...
Moderna to Present at Upcoming Conferences in March 2022
CAMBRIDGE, MA / ACCESSWIRE / March 2, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics...
Celcuity to Participate in the Cowen 42nd Annual Health Care Conference
MINNEAPOLIS, MN / ACCESSWIRE / March 2, 2022 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company pursuing an integrated therapeutic...
Panacea Life Sciences, Inc. Expands Premium Skincare Line with Two New, Purpose-Driven CBD and CBG Products
GOLDEN, CO / ACCESSWIRE / March 2, 2022 / Panacea Life Sciences, Inc. (OTCQB:PLSH), (the "Company"), a Colorado, USA-based biotech...
SPO Global Inc. Announces Strategic Cooperation Plan
Shandong, China, March 02, 2022 (GLOBE NEWSWIRE) -- SPO Global Inc. (OTC PINK: SPOM), a healthcare and biotech company, today...
HealthEquity Named One of the Nation’s Top Workplaces
Receives recognition after employees give HealthEquity high marks in national independent surveyDRAPER, Utah, March 02, 2022 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity”),...
Capricor Therapeutics Names Dr. Daniel Paulson as Vice President of Clinical Development
Dr. Paulson Will Lead Clinical Efforts Focused on Capricor’s Late-Stage Cell Therapy Program and its Expanding Exosome Platform--SAN DIEGO, March...
Avra, Inc., Operating as Springs Rejuvenation (AVRN), Expands Atlanta Operations
ATLANTA, GA, March 02, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Avra, Inc. (OTC PINK: AVRN), operating as Springs Rejuvenation, (“Spring”), a...
Shattuck Labs Announces Participation in Upcoming March Conferences
AUSTIN, TX and DURHAM, NC, March 02, 2022 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology...
Hillstream BioPharma R&D Day Highlights Ferroptosis, the Non-Genetic Novel, Emerging Mechanism of Action, Targeting Drug Resistant and Devastating Cancers
HSB-1216’s active moiety in clinical pilot study produced a 71% response rate in TNBC and epithelial carcinomasHSB-1216 was recently granted...
Yield10 Bioscience to Announce Fourth Quarter and Full Year 2021 Financial Results and Host a Conference Call on Wednesday, March 9, 2022
WOBURN, Mass., March 02, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company,...
ICU Medical, Inc. to Participate at the Raymond James 43rd Annual Institutional Investors Conference
SAN CLEMENTE, Calif., March 02, 2022 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and...